The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis
Open accessAbstract
BACKGROUND: Higher circulating levels of the branched-chain amino acids (BCAAs; i.e., isoleucine, leucine, and valine) are strongly associated with higher type 2 diabetes risk, but it is not known whether this association is causal. We undertook large-scale human genetic analyses to address this question. METHODS AND FINDINGS: Genome-wide studies of BCAA levels in 16,596 individuals revealed five genomic regions associated at genome-wide levels of significance (p < 5 × 10-8). The strongest signal was 21 kb upstream of the PPM1K gene (beta in standard deviations [SDs] of leucine per allele = 0.08, p = 3.9 × 10-25), encoding an activator of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) responsible for the rate-limiting step in BCAA catabolism. In another analysis, in up to 47,877 cases of type 2 diabetes and 267,694 controls, a genetically predicted difference of 1 SD in amino acid level was associated with an odds ratio for type 2 diabetes of 1.44 (95% CI 1.26-1.65, p = 9.5 × 10-8) for isoleucine, 1.85 (95% CI 1.41-2.42, p = 7.3 × 10-6) for leucine, and 1.54 (95% CI 1.28-1.84, p = 4.2 × 10-6) for valine. Estimates were highly consistent with those from prospective observational studies of the association between BCAA levels and incident type 2 diabetes in a meta-analysis of 1,992 cases and 4,319 non-cases. Metabolome-wide association analyses of BCAA-raising alleles revealed high specificity to the BCAA pathway and an accumulation of metabolites upstream of branched-chain alpha-ketoacid oxidation, consistent with reduced BCKD activity. Limitations of this study are that, while the association of genetic variants appeared highly specific, the possibility of pleiotropic associations cannot be entirely excluded. Similar to other complex phenotypes, genetic scores used in the study captured a limited proportion of the heritability in BCAA levels. Therefore, it is possible that only some of the mechanisms that increase BCAA levels or affect BCAA metabolism are implicated in type 2 diabetes. CONCLUSIONS: Evidence from this large-scale human genetic and metabolomic study is consistent with a causal role of BCAA metabolism in the aetiology of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, increased SCFA consumption may alleviate the hyperglycemic responses that are occurring in obese and type 2 diabetics, characterized by elevated amino-acid concentrations [154].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [154]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Andersen, C. L., Jensen, J. L., & Ørntoft, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0496 · Cited by 7,127
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
Self-citationDavey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
METAL: fast and efficient meta-analysis of genomewide association scans
Willer, C. J., Li, Y., & Abecasis, G. R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq340 · Cited by 5,205
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534
Self-citationAn atlas of genetic correlations across human diseases and traits
ReproGen Consortium, Bulik-Sullivan, B., Psychiatric Genomics Consortium, Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium 3, Finucane, H. K., Anttila, V., Gusev, A., Day, F. R., Loh, P.-R., Duncan, L., et al. (2015) · Nature Genetics · doi:10.1038/ng.3406 · Cited by 4,255
Self-citationGut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143
Cited by
Items 201–300 of 423
Yuan, S., Liu, M., He, Q., & Larsson, S. C. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.01.041 · Cited by 23
Hamaya, R., Mora, S., Lawler, P. R., Cook, N. R., Buring, J. E., Lee, I.-M. M., Manson, J. E., & Tobias, D. K. (2022) · Journal of Nutrition · doi:10.1093/jn/nxac056 · Cited by 24
Xu, H. Y., Wang, X., Geng, G., Xu, X., Liu, L., Zhang, Y., Wang, Z., Wang, L., & Li, Y. (2023) · Nutrients · doi:10.3390/nu15071580 · Cited by 24
“We removed three SNP loci in GCKR (rs1260326) [12,13], PPP2R3A (rs34894639), and NEU2 (rs2943652) for their known pleiotropic effect on multiple human complex traits, which could impact our findings.”
BackgroundBranched‐chain amino acids and type 2 diabetes: a bidirectional Mendelian randomization analysis
Mosley, J. D., Shi, M., Agamasu, D., Vaitinadin, N. S., Murthy, V. L., Shah, R. V., Bagheri, M., & Ferguson, J. F. (2024) · Obesity · doi:10.1002/oby.23951 · Cited by 26
“We did not observe associations previously reported near the tRNA methyl-transferase 61A ( TRMT61A ) and cerebellin 1 precursor ( CBLN1 ) gene in either the UK Biobank or METSIM cohorts (Table S3) [12].”
BackgroundResultInfluentialNokhoijav, E., Guba, A., Kumar, A., Kunkli, B., Kalló, G., Káplár, M., Somodi, S., Garai, I., Csutak, A., Tóth, N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094534 · Cited by 24
“Amino acids such as isoleucine, leucine, valine, and glycine were associated with the risk of development of T2D [29] and obesity [30], and correlations between the level of some amino acids with insulin resistance or glucose level were demonstrated [31].”
BackgroundBrunetta, H. S., Camargo, C. D. Q., & Nunes, E. A. (2018) · Amino Acids · doi:10.1007/s00726-018-2658-8 · Cited by 22
Chai, J. C., Chen, G., Yu, B., Xing, J., Li, J., Khambaty, T., Perreira, K. M., Perera, M. J., Vidot, D. C., Castañeda, S. F., et al. (2022) · Diabetes · doi:10.2337/db21-1056 · Cited by 22
Insulin Resistance and Impaired Branched-Chain Amino Acid Metabolism in Alzheimer’s Disease
Liu, R., Zhang, L., & You, H. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221147 · Cited by 19
“Suppression of BCAA catabolism is considered to be a major contributor to the elevated BCAA levels observed in obese and/or diabetic patients [92–94], which is supported by the results that the activity of BCAA catabolic enzymes are decreased in the liver and adipose tissue of ob/ob obese mice and…”
Schulze, M. B., Haardt, J., Amini, A. M., Kalotai, N., Lehmann, A. C., Schmidt, A., Buyken, A. E., Egert, S., Ellinger, S., Kroke, A., et al. (2023) · European Journal of Nutrition · doi:10.1007/s00394-023-03234-5 · Cited by 26
“Animal protein provides higher amounts of branched-chain amino acids compared to plant proteins, and circulating leucine, isoleucine, and valine may be risk factors for T2D [51].”
BackgroundSelf-citationFlores-Guerrero, J. L., Grzegorczyk, M. A., Connelly, M. A., Garcia, E., Navis, G. J., Dullaart, R. P. F., & Bakker, S. J. L. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103550 · Cited by 19
“because of their association with T2D [15], which has been shown to be causal [33].”
BackgroundHuang, C., Luo, Y., Zeng, B., Chen, Y., Liu, Y., Chen, W., Liao, X., Liu, Y., Wang, Y., & Wang, X. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109437 · Cited by 21
Hu, W., Liu, Z., Yu, W., Wen, S., Wang, X., Qi, X., Hao, H., Lu, Y., Li, J., Li, S., et al. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1965204 · Cited by 20
“Both SNPs were found to reach the genome-wide level of significance [7].”
BackgroundResultInfluentialGenome-wide association study for circulating metabolic traits in 619,372 individualsPreprint
Tambets, R., Kronberg, J., van der Graaf, A., Jesse, M., Abner, E., Võsa, U., Rahu, I., Taba, N., Kolde, A., Yarish, D., et al. (2024) · medRxiv · doi:10.1101/2024.10.15.24315557 · Cited by 19
“As a result, 12.4% of the independent lead variants detected in our analysis had a minor allele frequency (MAF) of less than 1% (Figure 3).”
InfluentialLu, Y., Li, G., Viallon, V., Ferrari, P., Freisling, H., Qiao, Y., Shao, L., Wu, L., Ding, Y., & Ke, C. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae167 · Cited by 19
Crisis of the Asian gut: associations among diet, microbiota, and metabolic diseases
Therdtatha, P., Shinoda, A., & Nakayama, J. (2022) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2021-085 · Cited by 25
“The results of four-week dietary interventions in overweight adults indicated that the Korean diet promotes gut microbial diversity and decreases the level of branched-chain amino acids, increased circulating levels of which are known to induce insulin resistance and aggravate glucose intolerance [50], which was the o…”
BackgroundA multivariant recall‐by‐genotype study of the metabolomic signature of BMI
Fang, S., Wade, K. H., Hughes, D. A., FitzGibbon, S., Yip, V., Timpson, N. J., & Corbin, L. J. (2022) · Obesity · doi:10.1002/oby.23441 · Cited by 16
Metabolomics Characterization of Disease Markers in Diabetes and Its Associated Pathologies
Pandey, S. (2024) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2024.0038 · Cited by 18
“22,36,37 Works by Concepcion included obese children with and without diabetes; the results showed metabolites related to the betaine pathway, nucleic acid metabolism, and BCAAs.”
Obesity Genomics and Metabolomics: a Nexus of Cardiometabolic Risk
Regan, J. A., & Shah, S. H. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01422-x · Cited by 19
Wang, W., Jiang, H., Zhang, Z., Duan, W., Han, T., & Sun, C. (2021) · Genes & Nutrition · doi:10.1186/s12263-021-00684-6 · Cited by 21
Nutritional Biomarkers, Gene-Diet Interaction, and Risk Factors for Type 2 Diabetes
Zheng, J., Niu, K., Jacobs, S., Dashti, H. S., & Huang, T. (2016) · Journal of Diabetes Research · doi:10.1155/2016/8610501 · Cited by 19
“In a recentMendelian randomization analysis, researchers identified a causal association of high circulating BCAAs with T2D risk and proved the causal role of BCAAmetabolism in the T2D etiology [9].”
BackgroundReshaping the Gut Microbiota Through Lifestyle Interventions in Women with PCOS: A Review
Ramadurai, S., & Balasundaram, U. (2022) · Indian Journal of Microbiology · doi:10.1007/s12088-022-01019-8 · Cited by 24
“[49] observed that the ingestion of more BCAAs causes type 2 diabetes.”
BackgroundJiang, W., Lu, K., Zhuang, Z., Wang, X., Tang, X., Huang, T., Gao, P., Wang, Y., & Du, J. (2023) · Metabolites · doi:10.3390/metabo13030403 · Cited by 19
“PPM1K has been found to be an important regulator of glucose metabolism and diabetes, which also revealed the casual association for type 2 diabetes [25].”
BackgroundMethodInfluentialKatagiri, R., Goto, A., Budhathoki, S., Yamaji, T., Yamamoto, H., KATO, Y. O., Iwasaki, M., & Tsugane, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-19388-w · Cited by 21
Ahola‐Olli, A., Mustelin, L., Kalimeri, M., Kettunen, J., Jokelainen, J. J., AUVINEN, J. P., Puukka, K. S., Havulinna, A. S., Lehtimäki, T. J., Kähönen, M. A. P., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/513648 · Cited by 17
Clinical metabolomics in type 2 diabetes mellitus: from pathogenesis to biomarkers
Liu, C., Chen, H., Ma, Y., Zhang, L., Chen, L., Huang, J., Zhao, Z., Jiang, H., & Kong, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1501305 · Cited by 22
“Clinical studies have shown that elevated BCAA levels are associated with the risk of T2DM (76, 77), and genetic studies have also con fi rmed the crucial role of BCAA metabolism in the development of DM (78).”
Silva, L. F., & Laakso, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083572 · Cited by 23
“However, there is no evidence that branched-chain amino acids are causally associated with insulin resistance and T2D [37].”
Hall, E. C. R., Semenova, E. A., Bondareva, E. A., Andryushchenko, L. B., Larin, A. K., Cięszczyk, P., Generozov, E. V., & Ahmetov, I. I. (2022) · Genes · doi:10.3390/genes13030397 · Cited by 16
“Previous investigations involved sedentary and/or T2D populations [18], and ours physically active participants.”
BackgroundInfluentialFonseca, T. A. H., Rekowski, C. P. V., Araújo, R., Oliveira, M. C., Justino, G. C., Bento, L. F. N., & Calado, C. R. C. (2023) · ACS Omega · doi:10.1021/acsomega.3c01370 · Cited by 16
Cai, S., Fu, Y., Chen, J., Tian, M., & Li, X. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032084 · Cited by 21
“23 The studies included in the GWAS were approved by the relevant institutional review committees, and participants provided informed consent.”
BackgroundAssessing the potential causal effects of 1099 plasma metabolites on 2099 binary disease endpoints
Yin, X., Li, J., Bose, D., Okamoto, J., Kwon, A., Jackson, A., Silva, L. F., Oravilahti, A., Chu, X., Stringham, H. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58129-2 · Cited by 16
“Additionally, while the primary exposure of interest is metabolites, the study explicates more from the lens of genetics, and dedicates less consideration for the ways in which metabolites also demonstrate correlation structure across pathways, and their lack of one-to-one pathway identity.”
Zheng, J., Li, K., Huang, T., Chen, Y., Xie, H., Xu, D., Sun, J., & Li, D. (2017) · Nutrients · doi:10.3390/nu9040376 · Cited by 17
Dairy consumption and hepatocellular carcinoma risk
Melnik, B. C. (2021) · Annals of Translational Medicine · doi:10.21037/atm-2020-ubih-06 · Cited by 18
“There is a confirmed association between elevated BCAA plasma levels and IR (25,124-133).”
BackgroundUsing Metabolomics in Diabetes Management with Traditional Chinese Medicine: A Review
He, Y., Zhang, H., Yang, Y., Yu, X., Zhang, X. L., Xing, Q., & Zhang, G. (2021) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x21500865 · Cited by 16
Li, J., Hu, J., Yun, H., Mei, Z., Wang, X., Luo, K., Guasch‐Ferré, M., Han, X., Truong, B. M. T., Merino, J., et al. (2026) · Nature Medicine · doi:10.1038/s41591-025-04105-8 · Cited by 31
“Second, although MR analysis is used frequently to infer causality between metabolites and diseases 47–49 , its results should be interpreted cautiously, because some metabolites have weak genetic instruments and many molecules within the same pathways share genetic loci.”
Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults: A Cross‐Sectional Study
Mann, J. P., Jenkins, B., Furse, S., Snowden, S. G., Alisi, A., Draijer, L. G., Karnebeek, K., Kelly, D. A., Koot, B. G. P., Mosca, A., et al. (2022) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003418 · Cited by 15
Self-citationActive role of amino acid metabolism in early diagnosis and treatment of diabetic kidney disease
Li, C., Gao, L., Lv, C., Li, Z., Fan, S., Liu, X., Rong, X., Huang, Y., & Liu, J. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1239838 · Cited by 17
Li, J., Yu, Y., Sun, Y. B., Fu, Y., Shen, W., Cai, L., Tan, X. W., Cai, Y., Wang, N., Lu, Y., et al. (2024) · eLife · doi:10.7554/elife.98709 · Cited by 24
“They also tended to have a family history of diabetes, comorbidities such as CVD, hypertension, dyslipidemia, and CLD, and higher levels of BMI, WC, and HC.”
Cellular reprogramming, chemoresistance, and dietary interventions in breast cancer
Pereira, I. C., Mascarenhas, I. F., Capetini, V. C., Ferreira, P. M. P., Rogero, M. M., & Torres‐Leal, F. L. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103796 · Cited by 18
Lotta, L. A., Pietzner, M., Stewart, I. D., Wittemans, L. B. L., Li, C., Bonelli, R., Raffler, J., Biggs, E. K., Oliver‐Williams, C., Auyeung, V. P. W., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.03.932541 · Cited by 15
Self-citationAssociation of plasma branched‐chain amino acids with overweight: A Mendelian randomization analysis
Liu, L., Wang, X., Liu, Y., Zhao, X., Xu, Z., Ma, Y., Xu, G., & Wen, D. (2021) · Obesity · doi:10.1002/oby.23240 · Cited by 14
“In order to construct an instrumental variable for plasma BCAA concentrations, we selected seven single- nucleotide polymorphisms (SNPs) confirmed to be associated with isoleucine, leucine, and/or valine levels in genomewide association studies (GWAS) from up to 16,500 individuals (24).”
MethodRivas‐Tumanyan, S., Pacheco, L. S., Haslam, D. E., Morou-Bermúdez, E., Liang, L., Tucker, K. L., JOSHIPURA, K. J., & Bhupathiraju, S. N. (2024) · Nutrients · doi:10.3390/nu16152562 · Cited by 14
“Isoleucine, leucine, and valine (and their derivatives, to some extent) have been studied extensively in relation to T2D risk in prospective observational cohorts [3–6] as well as in studies using Mendelian randomization methods [31,32].”
BackgroundMolecular Aspects of Lifestyle and Environmental Effects in Patients With Diabetes
Nayor, M. G., Shah, S. H., Murthy, V. L., & Shah, R. V. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.070 · Cited by 13
Liu, Y., Wu, H., Liu, B., Chen, S., Huang, L., Liu, Z., Wang, J., Xie, L., & Wu, X. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.06.040 · Cited by 16
Feng, S., Wang, J., Peng, Q., Zhang, P., Jiang, Y., Zhang, H., Song, X., Li, Y., Huang, W., Zhang, D., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156348 · Cited by 14
Islet hormones at the intersection of glucose and amino acid metabolism
White, P. J., Albrechtsen, N. J. W., & Campbell, J. E. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01100-4 · Cited by 17
“Accordingly, dysregulated amino acid homeostasis is now considered a hallmark of insulin resistance and a harbinger of T2DM 108–113 .”
InfluentialHaem biosynthesis regulates BCAA catabolism and thermogenesis in brown adipose tissue
Duerre, D. J., Hansen, J. K., John, S. V., Jen, A., Carrillo, N. D., Bui, H., Bao, Y., Fabregat, M., Catrow, J. L., Chen, L., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01253-6 · Cited by 14
“BCAAs are elevated in patients with obesity and diabetes and in obese– diabetic rodents and strongly associate with insulin resistance 8–10 .”
Pleiotropic and sex-specific genetic mechanisms of circulating metabolic markers
van der Meer, D., Rahman, Z., Ottas, A., Parekh, P., Kutrolli, G., Stinson, S. E., Koromina, M., Rokicki, J., Sønderby, I. E., Parker, N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60058-z · Cited by 16
“Branched chain amino acids, including valine, have been robustlyassociated with an increased riskofT2D 48 , whichmaybe driven by higher BMI and insulin resistance 49 .”
Wang, W., Liu, Z., Liu, L., Han, T., Yang, X., & Sun, C. (2021) · Genes & Nutrition · doi:10.1186/s12263-021-00695-3 · Cited by 17
Jersin, R. Å., Tallapragada, D. S. P., Skartveit, L., Bjune, M. S., Muniandy, M., Lee-Ødegård, S., Heinonen, S., Alvarez, M., Birkeland, K. I., Drevon, C. A., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad148 · Cited by 15
Sawicki, K. T., Ning, H., Allen, N. B., Carnethon, M. R., Wallia, A., Otvos, J. D., Ben‐Sahra, I., McNally, E. M., Snell‐Bergeon, J. K., & Wilkins, J. T. (2023) · JCI Insight · doi:10.1172/jci.insight.166956 · Cited by 18
“Previous human Mendelian randomization studies have demonstrated that polymorphisms near the PPM1K gene (encoding branched chain alpha-keto acid dehydrogenase complex phosphatase) are associated with higher circulating BCAA levels and higher DM risk, suggesting that elevated circulating BCAAs are contributory to DM pa…”
BackgroundMetabolite profiles of diabetes mellitus and response to intervention in anti-hyperglycemic drugs
Liu, Y., Wang, D., & Liu, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1237934 · Cited by 13
Otto, L., Budde, K., Kastenmüller, G., Kaul, A., Völker, U., Völzke, H., Adamski, J., Kühn, J., Krumsiek, J., Artati, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58430-8 · Cited by 14
Rigamonti, A. E., Frigerio, G., Caroli, D., Col, A. D., Cella, S. G., Sartório, A., & Fustinoni, S. (2023) · Nutrients · doi:10.3390/nu15030529 · Cited by 15
“In patients with obesity and T2DM, the disrupted protein metabolism may be envisaged in a net catabolic state due to increased loss of nitrogen or negative nitrogen balance, which means amino acid catabolism even without protein restriction.”
BackgroundInfluentialNajafi, F., Mohseni, P., Pasdar, Y., Niknam, M., & Izadi, N. (2023) · BMC Public Health · doi:10.1186/s12889-023-17210-5 · Cited by 12
“Furthermore, a large-scale Mendelian randomization analysis identified genetic instruments reflecting higher levels of circulating branched-chain species that are also associated with diabetes risk, suggesting a causal role of branched-chain amino acid metabolism in the development of diabetes [36].”
BackgroundKivelä, J., Meinilä, J. M., Uusitupa, M. I. J., Tuomilehto, J. O., & Lindström, J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac463 · Cited by 14
“Gene variants (34), metabolism in white adipose tissue and liver cells (35), the gut microbiome (36), lipid accumulation in muscle cells (37), and decreased tryptophan metabolism in the nervous system (38) are some examples of suggested mechanisms linking BCAA overload with T2D.”
BackgroundXuan, L., Hou, Y., Wang, T., Li, M., Zhao, Z., Lu, J., Xu, Y., Chen, Y., Qi, L., Wang, W., et al. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1165-4 · Cited by 16
“Rs1440581 near PPM1K gene was first identified in large-scale GWAS and consistently validated as strongest and leading signal of genetic predisposition to diabetes risk in relation to circulating BCAAs [4, 5].”
Dhanani, Z., Mann, G., & Adegoke, O. A. J. (2019) · Physiological Reports · doi:10.14814/phy2.14299 · Cited by 12
“, 2009; Wijekoon, Skinner, Brosnan, & Brosnan, 2004) and related metabolic diseases such as type 2 diabetes (Kuzuya et al., 2008; Lotta et al., 2016) and cardiovascular disease (Uddin et al.”
BackgroundBranched-chain Amino Acid Catabolism by Brown Adipose Tissue
Carpentier, A. C. (2020) · Endocrinology · doi:10.1210/endocr/bqaa060 · Cited by 12
“Epidemiological and genetic studies suggest a role for increased levels and reduced catabolic rate of branched-chain amino acids (BCAAs, ie, leucine, isoleucine, valine) in the development of type 2 diabetes (1,2).”
BackgroundGunther, S. H., Khoo, C. M., Sim, X., Tai, E. S., & van Dam, R. M. (2020) · Nutrients · doi:10.3390/nu12092603 · Cited by 12
“Evidence from Mendelian randomization studies support a causal role for BCAA species in diabetes development [23].”
BackgroundResultJäger, S., Cuadrat, R. R. C., Wittenbecher, C., Floegel, A., Hoffmann, P., Prehn, C. P., Adamski, J., Pischon, T., & Schulze, M. B. (2020) · Nutrients · doi:10.3390/nu12123890 · Cited by 14
“However, our multivariable approach combining all diabetes-associated amino acids into one model yielded no direct effect for BCAA, glycine, phenylalanine, or tryptophan.”
BackgroundResultInfluentialUeno, S., Seino, Y., Hidaka, S., Maekawa, R., Takano, Y., Yamamoto, M., Hori, M., Yokota, K., Masuda, A., Himeno, T., et al. (2022) · Nutrients · doi:10.3390/nu14050975 · Cited by 12
Otto, G., Kaisaki, P. J., Brial, F., Lay, A. L., Cazier, J., Mott, R., & Gauguier, D. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.038539 · Cited by 12
Laya, A., Wangso, H., Fernandes, I., Djakba, R., Oliveira, J., & Carvalho, E. (2023) · Journal of Food Quality · doi:10.1155/2023/5236509 · Cited by 16
Branched chain amino acids harbor distinct and often opposing effects on health and disease
Avery, C. L., Howard, A. G., Lee, H., Downie, C. G., Lee, M. P., Koenigsberg, S. H., Ballou, A. F., Preuss, M. H., Raffield, L. M., Yarosh, R., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00382-x · Cited by 14
Hirata, A., Harada, S., Iida, M., Kurihara, A., Fukai, K., Kuwabara, K., Kato, S., Matsumoto, M., Sata, M., Miyagawa, N., et al. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64616 · Cited by 14
Regional fat depot masses are influenced by protein-coding gene variants
Neville, M. J., Wittemans, L. B. L., Pinnick, K. E., Todorčević, M., Kaksonen, R., Pietiläinen, K. H., Luan, J., Scott, R. A., Wareham, N. J., Langenberg, C., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217644 · Cited by 12
Self-citationTobias, D. K., Mora, S., Verma, S., Billia, F., Buring, J. E., & Lawler, P. R. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154391 · Cited by 12
“Tobias, ScD(1),(2), Samia Mora, MD MSc(1),(3),(4), Subodh Verma, MD PhD(5), Filio Billia, MD PhD(6),(7),(8), Julie E.”
BackgroundNext-generation epidemiology: the role of high-resolution molecular phenotyping in diabetes research
Franks, P. W., & Pomares‐Millan, H. (2020) · Diabetologia · doi:10.1007/s00125-020-05246-w · Cited by 13
A new era of understanding in vivo metabolic flux in thermogenic adipocytes
Haley, J. A., Jang, C., & Guertin, D. A. (2023) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2023.102112 · Cited by 11
Jia, R., Chen, J., Lockhart, S. M., Lam, B., Kentistou, K. A., Zhao, Y., Gardner, E. J., Perry, J. R. B., O’Rahilly, S., Day, F. R., et al. (2025) · Diabetes · doi:10.2337/db24-1162 · Cited by 13
Self-citationUrbanization in China is associated with pronounced perturbation of plasma metabolites
Wang, Y., Sha, W., Wang, H., Howard, A. G., Tsilimigras, M. C. B., Zhang, J., Su, C., Wang, Z., Zhang, B., Fodor, A. A., et al. (2020) · Metabolomics · doi:10.1007/s11306-020-01724-9 · Cited by 9
Amino acid homeostasis is a target of metformin therapy
Forteath, C., Mordi, I. R., Nisr, R. B., Gutierrez-Lara, E. J., Alqurashi, N., Phair, I. R., Cameron, A., Beall, C., Bahr, I., Mohan, M., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101750 · Cited by 13
“Our observations also suggest that more than one cell type may contribute to effects of metformin on amino acids and might also contribute towards previously observed association of DM with elevated plasma BCAA [93].”
BackgroundLuo, S., Lam, H. S., Chan, Y. H., Tang, C. S.-M., He, B., Kwok, M. K., Leung, G. M., Schooling, C. M., & Yeung, S. L. A. (2023) · BMC Medicine · doi:10.1186/s12916-023-03115-y · Cited by 10
“…metabolomic panel, i.e., amino acids, fatty acids, fluid balance, glycolysis-related metabolites, inflammation, and ketone bodies as safety outcomes given some of these metabolites (e.g., branched chain amino acid) may be related to cardio-metabolic diseases [21, 22] (Additional file 1: Table S2).”
BackgroundMetabolomic correlates of central adiposity and earlier-life body mass index
Wulaningsih, W., Proitsi, P., Wong, A., Kuh, D. J., & Hardy, R. (2019) · Journal of Lipid Research · doi:10.1194/jlr.p085944 · Cited by 9
“Systemic metabolites have been reported to be altered with lipid medications (22), diabetes (23), and other chronic diseases (24).”
BackgroundBäßler, S. C., Kenéz, Á., Scheu, T., Koch, C., Meyer, U., Dänicke, S., & Huber, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-92163-6 · Cited by 16
A new branch connecting thermogenesis and diabetes
Sun, H., & Wang, Y. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0112-1 · Cited by 10
Zhao, J. V., Fan, B., & Burgess, S. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117246 · Cited by 14
Self-citationLing, C., Vaváková, M., Mir, B. A., Säll, J., Perfilyev, A., Martin, M., Jansson, P., Davegårdh, C., Asplund, O., Hansson, O., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03789-y · Cited by 11
“PPM1K is involved in reducing circulating BCAAs and it increases insulin sensitivity [40].”
Singh, S. P., Sethi, R., Saxena, S. K., & Gupta, A. K. (2021) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2021.12 · Cited by 11
Branched Chain Amino Acids at the Edge Bet
Haydar, S., Lautier, C., & Grigorescu, F. (2018) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2018.238 · Cited by 13
Complications of acute otitis media in children: case reports and review of literature.
Adhami, M., & Tohme, S. M. (2010) · PubMed · Cited by 9
Hamaya, R., Sun, Q., Li, J., Yun, H., Wang, F., Curhan, G. C., Huang, T., Manson, J. E., Willett, W. C., Rimm, E. B., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.05.010 · Cited by 9
Mann, G., & Adegoke, O. A. J. (2024) · Journal of Nutritional Science · doi:10.1017/jns.2024.66 · Cited by 10
“(45) Also, BCAA oxidation and levels of BCAA catabolic enzymes in skeletal muscle are reduced in insulin-resistant states.”
BackgroundNishimura, E. S., Hishikawa, A., Nakamichi, R., Akashio, R., Chikuma, S., Hashiguchi, A., Yoshimoto, N., Hama, E. Y., Maruki, T., Ito, W., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59297-x · Cited by 13
“According to a recent report, BCAAs are negatively correlated with insulin sensitivity, independent of BMI, and BCAA levels are elevated in the serum of individuals with type 2 diabetes 28,29 .”
Møller, P. M., Kjøbsted, R., Petersen, M. H., de Almeida, M. E., Pedersen, A. J. T., Wojtaszewski, J. F. P., & Højlund, K. (2025) · Diabetologia · doi:10.1007/s00125-025-06454-y · Cited by 11
“Earlier genome-wide association studies (GWAS) suggested that elevated plasma BCAAs contribute to the risk of type 2 diabetes [38], while more recent reports have provided evidence for a causal role of insulin resistance on plasma BCAAs [9, 10].”
Scientific Advances in Diabetes: The Impact of the Innovative Medicines Initiative
Brito, M. D. F., Torre, C., & Lima, B. S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.688438 · Cited by 8
“The scientific dimension would include the acquisition of more biological samples and genetic data and with the help of SUMMIT, IMIDIA, EBiSC, StemBANCC, EMIF, and IMI2PACT promote the research on β-cells as well as validate new biomarkers, genetic markers, patient stratification, discover more molecular mechanisms/pa…”
BackgroundInfluentialZhao, E., Giamberardino, S. N., Pagidipati, N. J., Voora, D., Ginsburg, G. S., Hoffmann, U., Karády, J., Ferencik, M., Douglas, P. S., Foldyna, B., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028410 · Cited by 8
Metabolomic Signatures and Metabolic Complications in Childhood Obesity
Balikcioglu, P. G., & Newgard, C. B. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-68192-4_21 · Cited by 7
Branched chain amino acids and risk of breast cancerPreprint
Zeleznik, O. A., Balasubramanian, R., Ren, Y., Tobias, D. K., ROSNER, B. A., Peng, C., Bever, A. M., Frueh, L., Clish, C. B., Mora, S., et al. (2020) · medRxiv · doi:10.1101/2020.08.31.20185470 · Cited by 8
Bocher, O., Singh, A., Huang, Y., Võsa, U., Reimann, E., Arruda, A. L., Barysenka, A., Kolde, A., Rayner, N. W., Esko, T., et al. (2024) · PLoS Genetics · doi:10.1371/journal.pgen.1011346 · Cited by 8
Off-target depletion of plasma tryptophan by allosteric inhibitors of BCKDK
Bowman, C. E., Neinast, M. D., Kawakami, R., Forelli, N., Jang, C., Patel, J. D., Blair, M. C., Noji, M., Mirek, E. T., Jonsson, W. O., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102165 · Cited by 12
“A Mendelian randomization study also showed that polymorphisms that cause elevations in circulating BCAAs also predict IR [7].”
Yogurt and health: a focus on its matrix
Tremblay, A., Drouin‐Chartier, J., Marette, A., & Drapeau, V. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2524472 · Cited by 11
“…revealed that BCAA levels are strongly associated with a SNP near the PPM1K (also referred to as PP2Cm) gene, which encodes the phosphatase that dephosphorylates and activates the branched-chain ketoacid dehydrogenase (BCKDH) complex, the first committed step in BCAA catabolism (Lotta et al. 2016).”
The omics revolution in obesity: from molecularsignatures to clinical solutions
Mustafa, M., Arafat, A. A., Alhazzani, W. A., Kunnathodi, F., Azmi, S., Riyasdeen, A., Ahmad, I., & Alotaibi, H. F. (2025) · Molecular Omics · doi:10.1039/d5mo00074b · Cited by 8
N-Palmitoyl Glutamine Is a Candidate Mediator of Cardiorespiratory Fitness
Robbins, J., Benson, M. D., Verkerke, A. R. P., Tiwari, G., Deng, S., Rao, P., Tahir, U. A., Ávila-Pacheco, J., Shi, X. D., Guan, Y., et al. (2025) · Circulation · doi:10.1161/circulationaha.125.074187 · Cited by 7
Lin, H., Ho, M., Wang, B., Mansoori, S., Yang, Y., Wang, W., So, P. K., Xu, A., Yang, S., Chang, J., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70004-2 · Cited by 11
“Although leucine and its direct catabolite α -ketoisocaproate (KIC) trigger β -cell acute insulin secretion 19 – 21 , genetic alleles associated with high leucine levels correlate negatively with the homeostasis model assessment of β -cell function (HOMA-β ) in diabetic patients 22 .”
Vigers, T., VINOVSKIS, C. L., Li, L., Prasad, P. V., Heerspink, H. J. L., D’Alessandro, A., Reisz, J. A., Piani, F., Cherney, D. Z. I., van Raalte, D. H., et al. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05531-3 · Cited by 7
Kouzu, H., Yano, T., Katano, S., Kawaharata, W., Ogura, K., Numazawa, R., Nagaoka, R., Ohori, K., Nishikawa, R., Ohwada, W., et al. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14872 · Cited by 8
Oza, M., Becker, W., Gummadidala, P. M., Dias, T., Omebeyinje, M. H., Chen, L., Mitra, C., Jesmin, R., Chakraborty, P., Sajish, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46478-0 · Cited by 8
Wallenius, V., Elebring, E., Casselbrant, A., Laurenius, A., le Roux, C. W., Docherty, N. G., Biörserud, C., Björnfot, N., Engström, M., Marschall, H., et al. (2021) · Nutrients · doi:10.3390/nu13103322 · Cited by 8
Tobias, D. K., Hamaya, R., Clish, C. B., Liang, L., Deik, A., Dennis, C., Bullock, K. H., Zhang, C., Hu, F. B., & Manson, J. E. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3763 · Cited by 10
“26,27 Elevated aromatic amino acids, tyrosine and phenylalanine, have been implicated in insulin resistance possibly through their impairment to insulin receptor signalling.”
Background
Metadata
- Authors
- Lotta, L. A., Scott, R. A., Sharp, S. J., Burgess, S., Luan, J., Tillin, T., Schmidt, A. F., Imamura, F., Stewart, I. D., Perry, J. R. B., Marney, L., Koulman, A., Karoly, E. D., Forouhi, N. G., Sjögren, R. J. O., Näslund, E., Zierath, J. R., Krook, A., Savage, D. B., Griffin, J. L., Chaturvedi, N., Hingorani, A. D., Khaw, K.-T., Barroso, I., McCarthy, M. I., O’Rahilly, S., Wareham, N. J., & Langenberg, C.
- Affiliations
- University of Cambridge (GB)
- University College London (GB)
- MRC Elsie Widdowson Laboratory (GB)
- Metabolon (United States) (US)
- Karolinska Institutet (SE)
- Danderyds sjukhus (SE)
- Centre for Human Genetics (GB)
- Corresponding author
- Wareham, Nicholas J.
- Langenberg, Claudia
- ORCID
- Lotta, Luca A.
- Scott, Robert A.
- Sharp, Stephen J.
- Burgess, Stephen
- Luan, Jian’an
- Tillin, Therese
- Schmidt, Amand F.
- Imamura, Fumiaki
- Perry, John R. B.
- Marney, Luke
- Koulman, Albert
- Karoly, Edward D.
- Forouhi, Nita G.
- Sjögren, Rasmus J. O.
- Näslund, Erik
- Zierath, Juleen R.
- Krook, Anna
- Savage, David B.
- Griffin, Julian L.
- Chaturvedi, Nishi
- Hingorani, Aroon D.
- Khaw, Kay-Tee
- Barroso, Inês
- McCarthy, Mark I.
- O’Rahilly, Stephen
- Wareham, Nicholas J.
- Langenberg, Claudia
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-11-29
- Volume
- 13
- Issue
- 11
- Pages
- e1002179
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC5127513
- OpenAlex
- W2559236589
- Cited by
- 417
- References
- 73
- Citations by year
- 2026: 20 · 2025: 38 · 2024: 43 · 2023: 50 · 2022: 49 · 2021: 61 · 2020: 50 · 2019: 31 · 2018: 52 · 2017: 21 · 2016: 1
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Medical Research Council (MC_UU_12015/1, MC_PC_13046, MC_PC_13048 and MR/L00002/1 - MRC Epidemiology Unit, MC_UP_A090_1006 - MRC Human Nutrition Research, SABRE Study)
- National Institute for Health Research (Biomedical Research Centre—MRC Epidemiology Unit)
- EMIF (n° 115372)
- Cambridge Lipidomics Biomarker Research Initiative (G0800783 - MRC Epidemiology Unit and MRC Human Nutrition Research)
- Diabetes UK (SABRE Study)
- British Heart Foundation (GB) (SABRE Study)
- Wellcome Trust (GB) (WT082464 - SABRE Study, SP/07/001/23603 - SABRE Study)
- Diabetes UK (GB) (13/0004774 - SABRE Study)
- Vetenskapsrådet (Rasmus J O Sjögren, Erik Näslund, Juleen R. Zierath and Anna Krook)
- Novo Nordisk Foundation (Rasmus J O Sjögren, Erik Näslund, Juleen R. Zierath and Anna Krook)
- Diabetes Wellness (Rasmus J O Sjögren, Erik Näslund, Juleen R. Zierath and Anna Krook)
- Wellcome Trust (107064, 090532, 098381, WT098051)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
- Keywords
- branched-chain amino acids, type 2 diabetes, branched-chain amino acid metabolism, PPM1K, branched-chain ketoacid dehydrogenase, genetic susceptibility, causal inference, isoleucine, leucine, valine, circulating amino acids, polygenic risk score, heritability, pleiotropy, mitochondrial metabolism, metabolite accumulation
- MeSH terms
- Adult, Aged, Amino Acids, Branched-Chain, Diabetes Mellitus, Type 2, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Sweden, Genetic Predisposition to Disease, Genome-Wide Association Study, Young Adult, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.